Sangamo Therapeutics (SGMO) Tops Q3 Earnings and Revenue Estimates

Sangamo Therapeutics (SGMO) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of$ 0.03 per share. This compares to loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 233.33%. A quarter ago, it was expected that this drug developer would post a loss of$ 0.16 per share when it actually produced a loss of $0.17, delivering a surprise of -6.25%.Over the last four quarter ...